The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potential clinical activity of pembrolizumab monotherapy in ovarian sex cords, rare epithelial carcinoma, and other rare ovarian tumor histotypes: The French AcSé pembrolizumab study from Unicancer.
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; BMS; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Roche; Seagen; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Emmanuelle Bompas
No Relationships to Disclose
 
Elodie Coquan
No Relationships to Disclose
 
Patrick Soulie
Travel, Accommodations, Expenses - Ipsen; Pfizer; PharmaMar
 
Sophie Cousin
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Diego Tosi
Consulting or Advisory Role - Actelion (I); Biomarin (I); Brenus Pharma
Research Funding - Astellas Pharma; Bayer; Ipsen; Janssen
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Amicus Therapeutics (I); AstraZeneca; AstraZeneca; Biomarin (I); Ipsen; Janssen; Janssen; MSD; Nutricia (I); Pfizer
 
Pierre Etienne Heudel
Honoraria - Amgen; AstraZeneca (Inst); Mylan; Novartis (Inst); Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Lilly; Novartis (Inst); Seagen
Research Funding - Fresenius (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Cyril Abdeddaim
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca (Inst); GlaxoSmithKline; MSD Oncology (Inst)
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); MSD Oncology (Inst); MSD vaccin (Inst); Onxeo (Inst); PharmaMar (Inst)
Research Funding - Onxeo (Inst); PharmaMar (Inst)
Expert Testimony - Clovis Oncology (Inst); Onxeo (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology; OSE Immunotherapeutics; Roche
 
Elsa Kalbacher
Honoraria - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; LEO Pharma; Roche; Tesaro/GSK
 
Frederic Selle
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; MSD; Sandoz
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Speakers' Bureau - AstraZeneca; GlaxoSmithKline/Tesaro; MSD
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro; MSD; Roche
 
Anne Floquet
No Relationships to Disclose
 
Laetitia Gambotti
No Relationships to Disclose
 
Clotilde Simon
No Relationships to Disclose
 
Assia Lamrani-Ghaouti
No Relationships to Disclose
 
Sylvie Chevret
No Relationships to Disclose
 
Caroline Even
Consulting or Advisory Role - Bristol-Myers Squibb; Innate Pharma; Merck Serono; MSD Oncology